24
Participants
Start Date
June 23, 2023
Primary Completion Date
February 21, 2024
Study Completion Date
February 21, 2024
Virtual-reality (VR) Based Solution
VR-based solution comprises a mobile phone application including explanation on the different steps to be followed to perform infusions in satisfactory conditions, notably as regards safety, as well as VAS for pain and anxiety to be completed at each Factor VIII or Factor IX infusion between inclusion and the Week 4 visit. It also comprises a 3D mask (to be used before or during infusions) including simulation of the infusions themselves (before infusion) and a relaxing and distracting content (during and after infusions).
Hôpital Hôtel-Dieu, Nantes
Hôpital de Hautepierre - Pôle MIRMED, Strasbourg
CHU Purpan, Toulouse
CHU Pellegrin, Bordeaux
CHU Estaing, Clermont-Ferrand
Centre de Reference Hemophilie Unite D'Hemostase Clinique, Bron
Lead Sponsor
Takeda
INDUSTRY